MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.

: To evaluate magnetic resonance imaging (MRI) findings, according to Breast Imaging-Reporting and Data System (BI-RADS), and to relate them with molecular subtypes of breast cancer. The MRI findings were reviewed retrospectively in 201 women diagnosed of invasive breast cancer confirmed by surgery and were compared with the molecular subtypes. Following the BI-RADS, MRI findings included disease type, size, enhancement, morphology and contrast kinetics. In mass-like lesion types were studied shape, margin and enhancement, and in nonmass-like lesion types, distribution modifiers and internal enhancement. Chi-squared analysis showed significant association (p < 0.01) between molecular subtypes and lesion type on MRI and histologic grade. Shape, margin and mass enhancement (p < 0.05) also showed significant association among molecular subtypes. Triple negative were more frequently unifocal and mass-like lesion, high histologic grade, round shape, smooth margin, and rim enhancement. Luminal-A were more frequently low grade, mass-like lesion, irregular shape and spiculated or irregular margin. Luminal-B were more frequently moderate-low grade, mass-like lesion, nonirregular shape and spiculated margin. HER-2-enriched were more frequently moderate grade, nonmass-like lesion and multicentric lesions were more present than in other subtypes. There are significantly different MRI features, according to BI-RADS, between the molecular subtypes breast cancer.

[1]  Marcia Koomen,et al.  Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. , 2006, Academic radiology.

[2]  Thomas E Yankeelov,et al.  Magnetic resonance in the era of molecular imaging of cancer. , 2011, Magnetic resonance imaging.

[3]  Eun-Kyung Kim,et al.  Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes , 2012, European Radiology.

[4]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[5]  Eun Sook Ko,et al.  Triple-negative breast cancer: correlation between imaging and pathological findings , 2010, European Radiology.

[6]  Elizabeth A. Morris,et al.  Advances in breast imaging: Magnetic resonance imaging , 2006, Current oncology reports.

[7]  S. Jeffrey,et al.  Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. , 2008, Radiology.

[8]  Dae Young Seo,et al.  Magnetic resonance imaging of breast cancer and correlation with prognostic factors , 2009, Acta radiologica.

[9]  R. Warren,et al.  Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[11]  A. Tutt,et al.  Triple negative tumours: a critical review , 2007, Histopathology.

[12]  T. Uematsu,et al.  Triple-negative breast cancer: correlation between MR imaging and pathologic findings. , 2009, Radiology.

[13]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[14]  I. Ellis,et al.  Preoperative assessment of prognostic factors in breast cancer , 2001, Journal of clinical pathology.

[15]  N. Hylton,et al.  Magnetic resonance imaging of the breast prior to biopsy. , 2004, JAMA.

[16]  C. Kuhl,et al.  Mammographic, US, and MR imaging phenotypes of familial breast cancer. , 2008, Radiology.

[17]  Ian O Ellis,et al.  Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Tunçbilek,et al.  Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. , 2005, European journal of radiology.

[19]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[20]  R. Ponzone,et al.  Correlations between diffusion-weighted imaging and breast cancer biomarkers , 2012, European Radiology.

[21]  C. V. van Deurzen,et al.  Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgery. , 2013, AJR. American journal of roentgenology.

[22]  Massimo Bazzocchi,et al.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.

[23]  Les Irwig,et al.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Rodenhuis,et al.  Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Sismondi,et al.  Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer , 2007, European Radiology.

[26]  Uwe Fischer,et al.  The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer , 2004, European Radiology.